Characterization of Rifampin-Resistant Staphylococcus Aureus Nasal Carriage in Patients Receiving Rifampin-Containing Regimens for Tuberculosis

Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s163634
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Methicillin-Resistant Staphylococcus Aureus Nasal Carriage Among Patients Receiving Hemodialysis in Taiwan: Prevalence Rate, Molecular Characterization and De-Colonization

BMC Infectious Diseases
Infectious Diseases
2012English

Nasal Carriage of Resistant Staphylococcus Aureus in a Medical Student Community

Anais da Academia Brasileira de Ciencias
Multidisciplinary
2016English

Interaction Between Vancomycin and Rifampin Against Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

Molecular Characterization of Rifampin-Resistant Neisseria Meningitidis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Nasal Carriage of Staphylococcus Aureus and Methicillin-Resistant S Aureus in the United States, 2001-2002

Annals of Family Medicine
Family Practice
2006English

Assessment of Nasal Carriage of Staphylococcus Aureus in Patients With Acne Vulgaris

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2015English

Bacterial and Host Factors Implicated in Nasal Carriage of Methicillin-Resistant Staphylococcus Aureus in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2005English

Oropharyngeal and Nasal Staphylococcus Aureus Carriage by Healthy Children

BMC Infectious Diseases
Infectious Diseases
2014English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy